Nanopublications

Matches in Nanopublications for { ?s ?p "[Mutations in the E-domain of RAR portion of the PML/RAR chimeric gene may confer clinical resistance to all-trans retinoic acid in acute promyelocytic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

Showing items 1 to 19 of 19 with 100 items per page.

NP289797.RAWA_4blmaQxAVZzXTpbZycQy3gdS8o3EvcHx4qPjesIA130_assertion description "[Mutations in the E-domain of RAR portion of the PML/RAR chimeric gene may confer clinical resistance to all-trans retinoic acid in acute promyelocytic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP289797.RAWA_4blmaQxAVZzXTpbZycQy3gdS8o3EvcHx4qPjesIA130_provenance.
NP531038.RAV2_Lf90eN8a9Zdl0atNaD-IPtbhjJKJqubyGvRi7i3g130_assertion description "[Mutations in the E-domain of RAR portion of the PML/RAR chimeric gene may confer clinical resistance to all-trans retinoic acid in acute promyelocytic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP531038.RAV2_Lf90eN8a9Zdl0atNaD-IPtbhjJKJqubyGvRi7i3g130_provenance.
NP650824.RAhDuYBAG2TOkDZ-mDNxwi9HnpAi1fYDwowlhDXJ_XJ_A130_assertion description "[Mutations in the E-domain of RAR portion of the PML/RAR chimeric gene may confer clinical resistance to all-trans retinoic acid in acute promyelocytic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP650824.RAhDuYBAG2TOkDZ-mDNxwi9HnpAi1fYDwowlhDXJ_XJ_A130_provenance.
NP665659.RAfVacl69Rz1azOOuhJUEh46zFFmG2Ks_LW7wRjW2CD5A130_assertion description "[Mutations in the E-domain of RAR portion of the PML/RAR chimeric gene may confer clinical resistance to all-trans retinoic acid in acute promyelocytic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP665659.RAfVacl69Rz1azOOuhJUEh46zFFmG2Ks_LW7wRjW2CD5A130_provenance.
assertion description "[Mutations in the E-domain of RAR portion of the PML/RAR chimeric gene may confer clinical resistance to all-trans retinoic acid in acute promyelocytic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
assertion description "[Mutations in the E-domain of RAR portion of the PML/RAR chimeric gene may confer clinical resistance to all-trans retinoic acid in acute promyelocytic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
assertion description "[Mutations in the E-domain of RAR portion of the PML/RAR chimeric gene may confer clinical resistance to all-trans retinoic acid in acute promyelocytic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
assertion description "[Mutations in the E-domain of RAR portion of the PML/RAR chimeric gene may confer clinical resistance to all-trans retinoic acid in acute promyelocytic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
NP856870.RAj0-GJjPcTMr7Pne6yuIWNMgUsP_n2byX_6bHcCF36cM130_assertion description "[Mutations in the E-domain of RAR portion of the PML/RAR chimeric gene may confer clinical resistance to all-trans retinoic acid in acute promyelocytic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP856870.RAj0-GJjPcTMr7Pne6yuIWNMgUsP_n2byX_6bHcCF36cM130_provenance.
assertion description "[Mutations in the E-domain of RAR portion of the PML/RAR chimeric gene may confer clinical resistance to all-trans retinoic acid in acute promyelocytic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
assertion description "[Mutations in the E-domain of RAR portion of the PML/RAR chimeric gene may confer clinical resistance to all-trans retinoic acid in acute promyelocytic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
NP1398942.RAiGzyhoCJekIYX1bY-95wjJ6TyrW_Zu2iAVjIas1f6tk130_assertion description "[Mutations in the E-domain of RAR portion of the PML/RAR chimeric gene may confer clinical resistance to all-trans retinoic acid in acute promyelocytic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1398942.RAiGzyhoCJekIYX1bY-95wjJ6TyrW_Zu2iAVjIas1f6tk130_provenance.
NP1398946.RAqnLFog0Nk9e42zOCTBlg3Cvyfmgy0L-9Hj2JOS30exM130_assertion description "[Mutations in the E-domain of RAR portion of the PML/RAR chimeric gene may confer clinical resistance to all-trans retinoic acid in acute promyelocytic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1398946.RAqnLFog0Nk9e42zOCTBlg3Cvyfmgy0L-9Hj2JOS30exM130_provenance.
NP954865.RAIhtHVlclFslNJo1gpngDXV0Nvp5XAKpsF-SDaftMniw130_assertion description "[Mutations in the E-domain of RAR portion of the PML/RAR chimeric gene may confer clinical resistance to all-trans retinoic acid in acute promyelocytic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP954865.RAIhtHVlclFslNJo1gpngDXV0Nvp5XAKpsF-SDaftMniw130_provenance.
NP856827.RAMihzQVp0voWW0PdXSbPOtS5QN3iDKnRZ7She3vGtF1A130_assertion description "[Mutations in the E-domain of RAR portion of the PML/RAR chimeric gene may confer clinical resistance to all-trans retinoic acid in acute promyelocytic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP856827.RAMihzQVp0voWW0PdXSbPOtS5QN3iDKnRZ7She3vGtF1A130_provenance.
NP1398944.RALeXIWf1XhXxD4IHuuxbb4TpzskfxaNGtd8OoP-MN-w4130_assertion description "[Mutations in the E-domain of RAR portion of the PML/RAR chimeric gene may confer clinical resistance to all-trans retinoic acid in acute promyelocytic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1398944.RALeXIWf1XhXxD4IHuuxbb4TpzskfxaNGtd8OoP-MN-w4130_provenance.
NP1398945.RA_of3PnIMaxnsmD7OrFw4is4GwqehqrH-UtXEu6U0YC0130_assertion description "[Mutations in the E-domain of RAR portion of the PML/RAR chimeric gene may confer clinical resistance to all-trans retinoic acid in acute promyelocytic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1398945.RA_of3PnIMaxnsmD7OrFw4is4GwqehqrH-UtXEu6U0YC0130_provenance.
NP1398947.RAzHl9lwWcolGVyGfCzRbT3W45mDIJRrQvRjVqX-Hakgc130_assertion description "[Mutations in the E-domain of RAR portion of the PML/RAR chimeric gene may confer clinical resistance to all-trans retinoic acid in acute promyelocytic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1398947.RAzHl9lwWcolGVyGfCzRbT3W45mDIJRrQvRjVqX-Hakgc130_provenance.
NP1398948.RA36_mR5o2JgeIdvhBeUAZYDQjlLaYSHgC0lJPmS8r8Aw130_assertion description "[Mutations in the E-domain of RAR portion of the PML/RAR chimeric gene may confer clinical resistance to all-trans retinoic acid in acute promyelocytic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1398948.RA36_mR5o2JgeIdvhBeUAZYDQjlLaYSHgC0lJPmS8r8Aw130_provenance.